| Sector |
Trading
|
Compare with Sector peers |
| Industry |
Trading
|
Compare with Industry peers |
| Website | http://www.vivanzabiosciences.com | |
| Market Cap | 32.12 Cr. | |
| Enterprise Value(EV) | 37.39 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 0.21 | Trailing Twelve Months Ending 2023-12 |
| Price-Earning Ratio (PE) | 37.44 | Trailing Twelve Months Ending 2023-12 |
| Industry PE | 65.67 | Trailing Twelve Months Ending 2023-12 |
| Book Value / Share | 1.26 | Trailing Twelve Months Ending 2023-12 |
| Price to Book Value | 6.36 | Calculated using Price: 8.03 |
| Dividend Yield | 0.00 | Period Ending 2023-03 |
| No. of Shares Subscribed | 4.00 Cr. | 40,000,000 Shares |
| FaceValue | 1 | |
| About Vivanza Biosciences Ltd. | ||
| The company is engaged in the business of business of Pharmaceutical Products. | ||
| 1 Day |
|
-1.47% |
| 1 Week |
|
-2.90% |
| 1 Month |
|
+23.73% |
| 3 Month |
|
-2.07% |
| 6 Month |
|
-25.30% |
| 1 Year |
|
-52.68% |
| 2 Year |
|
-57.42% |
| 5 Year |
|
+322.63% |
| 10 Year |
|
+792.22% |
| 8 years | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | -242.6 | -17.54 | 5.66 | -12.56 | -6.46 | 2.41 | 10.01 | 15.78 | |
| Return on Capital Employed (%) | -11.38 | -10.82 | 12.73 | -0.4 | 5.74 | 17.11 | 12.25 | 10.91 | |
| Return on Assets (%) | -9.49 | -7.99 | 2.37 | -4.15 | -1.75 | 0.72 | 2.77 | 3.15 |
| Particulars | 9 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 0 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | |
| Non Curr. Liab. | 0 | 1 | 1 | 0 | 3 | 1 | 2 | |||
| Curr. Liab. | 1 | 3 | 6 | 7 | 9 | 5 | 9 | 17 | 22 | |
| Minority Int. | ||||||||||
| Equity & Liab. | 1 | 7 | 10 | 11 | 12 | 8 | 16 | 22 | 29 | |
| Non Curr. Assets | 1 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | |
| Curr. Assets | 0 | 4 | 7 | 8 | 9 | 5 | 12 | 20 | 26 | |
| Misc. Exp. not W/O | ||||||||||
| Total Assets | 1 | 7 | 10 | 11 | 12 | 8 | 16 | 22 | 29 |
| Particulars | 9 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
| Net Sales | 3 | 6 | 3 | 10 | 10 | 10 | 18 | 32 | ||
| Other Income | 0 | 1 | 1 | 1 | 0 | 0 | ||||
| Total Income | 4 | 6 | 3 | 10 | 10 | 11 | 18 | 32 | ||
| Total Expenditure | 0 | -4 | -6 | -3 | -10 | -10 | -10 | -17 | -30 | |
| PBIDT | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Depreciation | 0 | 0 | ||||||||
| Taxation | 0 | 0 | 0 | 0 | ||||||
| Exceptional Items | ||||||||||
| PAT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | |
| Minority Interest | ||||||||||
| Share Associate | ||||||||||
| Other Related Items | ||||||||||
| Consolidated Net Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | |
| Adjusted EPS | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Particulars | 8 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | -2 | 0 | 1 | 3 | -3 | 2 | -1 | ||
| Cash Fr. Inv. | 2 | 0 | |||||||
| Cash Fr. Finan. | 0 | -1 | -1 | -3 | 2 | -2 | 1 | ||
| Net Change | 0 | -1 | 0 | 0 | 0 | 0 | 0 | ||
| Cash & Cash Eqvt | -2 | -3 | -3 | -3 | -3 | 0 | 0 |
|
Sat, 20 Apr 2024
Compliance Under Regulation 40 (9) For The Financial Year Ended On 31St March 2024 With reference to captioned subject please find enclosed herewith certificate of practising company secretary under regulation 40(9) of SEBI(LODR) Regulations 2015. |
|
Fri, 19 Apr 2024
Board Meeting Intimation for (I) Audited Results For The Quarter And Year Ended On March 31St 2024.(Ii) Appointment Of Independent Director Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/04/2024 inter alia to consider and approve (i) Audited results for the quarter and year ended on March 31st 2024.(ii) Appointment of Independent Director |
|
Sat, 13 Apr 2024
Compliances-Reg.24(A)-Annual Secretarial Compliance Non Applicability of Reg. 24A_SEBI (LODR) Regulations 2015 |
| Thu, 25 Apr 2024 |
Opening at High
|
Closing Below Previous Low
|
Making Lower Lows for 3 days
|
Closing Below Previous Low for 2 Days
|
Making Lower Lows for 2 Days
|
